The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Considerable on MSN
Lilly’s Zepbound seen beating Pfizer injection
Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a ...
Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.
By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results